Product description

Biolevox™ HA 1.6% it's an injection of hyaluronic acid with optimal physicochemical propertie. Iindicated in pain and decreased articular mobility associated with traumatic or degenerative changes including osteoarthritis. 
The pre-filled syringe with 1 ml of gel is dedicated mostly for small joints, for instance: facet joint, metatarsophalangeal joint, carpometacarpal joint, temporomandibular joint, interphalangeal joints
Read more

Specifications

Categories Finished Dosage FormsInjectables; BiopharmaceuticalsRegenerative Medicine
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Poland
Biolevox™ HA 1.6%

Contact information

Address

Telephone

Website

View all contact information
CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Lonza

Lonza

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Elevate your expectations. Demand more from your CDMO.

Elevate your expectations. Demand more from your CDMO.

CONTENT GROUP

CONTENT GROUP